Sugi Predict

Sugi Predict / Compounds / Eprinomectin

Eprinomectin

Eprinomectin

SCHEMBL120548

CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@H](NC(C)=O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@H]1NC(C)=O

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ HSPD1 P10809 2/20 0.98
▸ HSPE1 P61604 2/20 0.98
▸ ADORA3 P0DMS8 1/20 0.86
▸ DRD1 P21728 1/20 0.86
▸ MEN1 O00255 2/20 0.84
▸ KMT2A Q03164 2/20 0.84
▸ USP2 O75604 1/20 0.84
▸ NPC1 O15118 1/20 0.69
▸ MTOR P42345 1/20 0.69
▸ RAB9A P51151 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Eprinomectin SCHEMBL29392105 1.00 HSPD1 (0.98) HSPD1HSPE1ADORA3DRD1MEN1
SCHEMBL19708763 0.99 HSPD1 (1.00) HSPD1HSPE1ADORA3DRD1MEN1
SCHEMBL248559 0.99 HSPD1 (1.00) HSPD1HSPE1ADORA3DRD1MEN1
SCHEMBL29355814 0.99 HSPD1 (1.00) HSPD1HSPE1ADORA3DRD1MEN1
SCHEMBL29523079 0.99 HSPD1 (1.00) HSPD1HSPE1ADORA3DRD1MEN1
SCHEMBL248270 0.99 HSPD1 (1.00) HSPD1HSPE1ADORA3DRD1MEN1
Propylene Glycol SCHEMBL9901967 0.98 HSPD1 (0.94) HSPD1HSPE1ADORA3DRD1MEN1
SCHEMBL31237191 0.97 HSPD1 (0.91) HSPD1HSPE1ADORA3DRD1MEN1
SCHEMBL19708888 0.97 HSPD1 (0.91) HSPD1HSPE1ADORA3DRD1MEN1
SCHEMBL3465034 0.97 HSPD1 (0.91) HSPD1HSPE1ADORA3DRD1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9594 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260139860-A1 PRODUCTS OF MANUFACTURE FOR THE TREATMENT, PREVENTION AND AMELIORATION OF MICROBIAL INFECTIONS CENTRE FOR DIGESTIVE DISEASES (AU) 2026-05-21 — — US claimed
US-20260137082-A1 FUNGICIDAL COMPOSITIONS COMPRISING FLUDIOXONIL SYNGENTA CROP PROTECTION AG (CH) 2026-05-21 — — US claimed
WO-2026041786-A1 INJECTABLE VETERINARY COMPOSITION AND USES THEREOF INTERVET INTERNATIONAL B.V. (NL) 2026-02-26 — — WO claimed
US-20260021076-A1 ISOXAZOLINE AND MACROCYCLIC LACTONE MICROSPHERES ZOETIS SERVICES LLC (US) 2026-01-22 — — US claimed
EP-4680248-A1 PRODUCTS OF MANUFACTURE AND THERAPEUTIC COMPOSITIONS FOR TREATING, AMELIORATING OR PREVENTING VIRAL INFECTIONS AND METHODS FOR MAKING AND USING THEM Topelia Aust Limited (ACN 652 771 670) (AU) 2026-01-21 — — EP claimed
EP-4665368-A1 FUCALES-BASED COMPOSITION FOR USE IN THE ORAL TREATMENT OF HELMINTHIASIS, AND METHOD FOR OBTAINING A CORRESPONDING PREPARATION Olmix (FR) 2025-12-24 — — EP claimed
US-12490741-B2 Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto CORTEVA AGRISCIENCE LLC (US) 2025-12-09 — — US claimed
WO-2025244856-A1 METHODS AND COMPOSITIONS RELATING TO ELQ COMPOUNDS OREGON HEALTH & SCIENCE UNIVERSITY (US) 2025-11-27 — — WO claimed
US-20250359552-A1 MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2025-11-27 — — US claimed
EP-3060043-B1 PESTICIDAL COMPOSITIONS AND RELATED METHODS CORTEVA AGRISCIENCE LLC (US) 2025-11-26 — — EP claimed
WO-2001060380-A1 A PARASITICIDAL FORMULATION AND A METHOD OF MAKING THIS FORMULATION PHOENIX SCIENTIFIC, INC. (US) 2001-08-23 — — WO claimed
CN-1293553-A Liquid polymer composition for controlled release of biologically active substances MERCK & CO INC (US) 2001-05-02 — — CN claimed
CN-1283990-A Long cating injectable formulations contg. hydrogenated castor oil MERCK & CO INC (US) 2001-02-14 — — CN claimed
US-6174540-B1 COMPRISING THEREPEUTIC AGENT SELECTED FROM INSECTICIDES, ACARICIDES, PARASITICIDES, GROWTH ENHANCERS, AND NASIDS; HYDROGENATED CASTOR OIL; HYDROPHOBIC CARRIER MERCK & CO., INC. 2001-01-16 — — US claimed
EP-1066854-A2 Anthelmintic compositions containing combinations of avermectins or milbemycins with bis-aryl compounds PFIZER INC. (US) 2001-01-10 — — EP claimed
EP-1063942-A1 LIQUID POLYMERIC COMPOSITIONS FOR CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES Merck & Co., Inc. (US) 2001-01-03 — — EP claimed
EP-1035835-A1 LONG ACTING INJECTABLE FORMULATIONS CONTAINING HYDROGENATED CASTOR OIL Merck & Co., Inc. (US) 2000-09-20 — — EP claimed
US-6114376-A REVERSING AGENT IS LL-F28249ALPHA-LAMBDA SERIES OF COMPOUNDS, THE 23-OXO OR 23-IMINO DERIVATIVE THEREOF, THE AVERMECTINS, THE 22,23-DIHYDRO DERIVATIVES THEREOF AND THE MILBEMYCINS MCGILL UNIVERSITY (CA) 2000-09-05 — — US claimed
WO-1999047073-A1 LIQUID POLYMERIC COMPOSITIONS FOR CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES MERCK & CO., INC. (US) 1999-09-23 — — WO claimed
WO-1999027906-A1 LONG ACTING INJECTABLE FORMULATIONS CONTAINING HYDROGENATED CASTOR OIL MERCK & CO., INC. (US) 1999-06-10 — — WO claimed